NCT06512012

Brief Summary

The study was planned to examine the effects of technology-supported yoga and exercise on chemotherapy-induced peripheral neuropathy and pain in children aged 5-18 years with leukemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at P25-P50 for not_applicable leukemia

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2021

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

August 28, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 22, 2024

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

2.5 years

First QC Date

August 28, 2023

Last Update Submit

July 19, 2024

Conditions

Keywords

yoga, excercise, pain, neuropathy, children, leukemia

Outcome Measures

Primary Outcomes (2)

  • Pediatric Modified Total Neuropathy Scale and Total Neuropathy Score-Pediatric Vincristine (TNS-PV) for peripheral neuropathy

    Pediatric Modified Total Neuropathy Scale and Total Neuropathy Score-Pediatric Vincristine (TNS-PV) assessment tools will be used. They determine Chemotherapy-induced Peripheral Neuropathy and its severity in children receiving cancer treatment. Each category is scored between 0-4. The highest 32 points are obtained from the scale. The higher the score, the worse the neuropathy. TNS-PV is based on adding constipation and hoarseness to the Pediatric Modified Total Neuropathy Scale.

    during 6 months (at the beginning of the study, 3rd month and 6th month)

  • Adolescent Pediatric Pain Scale for pain

    Adolescent Pediatric Pain Scale: This scale consists of three independent parts; 1. body outline diagram where the child/adolescent can mark the location of the pain \*Assessment: The child can mark the anterior and posterior sides-upper extremity, lower extremity, head, neck, abdomen, chest, shoulder, back… so that the location and number of the pain area is evaluated 2. 10 cm long, where the pain can mark the severity as "no pain, mild pain, moderate pain, very pain and worst pain possible" word chart scale \* Evaluation: With a scale of 0-10 cm, the pain is evaluated by the child between 0-10 and the pain is defined as "no pain, mild pain, moderate pain, very pain". and defines its intensity by choosing one of the "worst pain possible" 3. word list under 4 dimensions (sensory, emotional, evaluative, time) to indicate the nature of pain.

    during 6 months (at the beginning of the study, 3rd month and 6th month)

Secondary Outcomes (1)

  • Pediatric Symptom Screening Scale for chemotherapy related symptoms

    during 6 months (at the beginning of the study, 3rd month and 6th month)

Study Arms (2)

Yoga and exercise group

EXPERIMENTAL

Before starting yoga, "How are you feeling today?" will be asked to child. The yoga session will be individualized according to how the child feels. The content of the yoga sessions will progress in the form of warm-up exercises - breathing work - yoga postures (asana) - meditation - and progressive muscle relaxation exercises. Yoga sessions will be scheduled for 30 minutes. Yoga sessions and progressive muscle relaxation exercises will be held online once a week for eight weeks, then every two weeks for four months.

Behavioral: yoga and exercise

control group

NO INTERVENTION

no yoga or excersize intervention.

Interventions

Technology-Assisted Yoga and Exercise Intervention during 6 months

Yoga and exercise group

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age range of the child is between 6-18,
  • Diagnosed with acute lymphoblastic leukemia,
  • Induction (Steroid and Vincristine) treatment,
  • Being on an inpatient or outpatient treatment,
  • Newly diagnosed or on induction therapy for less than one month,
  • child agreeing to participate in the study voluntarily,
  • Parent agreeing to participate in the study voluntarily,
  • No relapse,
  • Obtaining the consent form from the child and the parent,
  • The child does not have a physical or psychological deficit,
  • The child's yoga and exercise have an electronic device and internet to participate in the intervention.

You may not qualify if:

  • The patient's relapse or terminal period,
  • The child and family are not willing to participate in the study,
  • The child has a cognitive, physical, and psychological deficits,
  • The child's illiteracy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gülçin Özalp Gerçeker

Izmir, 35100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

LeukemiaNeuritisPain

Interventions

YogaExercise

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesExercise Movement TechniquesPhysical Therapy ModalitiesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Gülçin Özalp Gerçeker, Assoc. Prof.

    Dokuz Eylul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

August 28, 2023

First Posted

July 22, 2024

Study Start

October 30, 2021

Primary Completion

April 30, 2024

Study Completion

June 30, 2024

Last Updated

July 22, 2024

Record last verified: 2024-07

Locations